Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 65 entries
Sorted by: Best Match Show Resources per page
Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance.

Journal of managed care pharmacy : JMCP

Gee M, Hasson NK, Hahn T, Ryono R.
PMID: 14613379
J Manag Care Pharm. 2002 Nov-Dec;8(6):453-8. doi: 10.18553/jmcp.2002.8.6.453.

OBJECTIVE: The primary objective was to determine the effect of a hydroxymethylglutaryl- CoA reductase inhibitor (HMG) tablet-splitting program on laboratory outcomes (lipid panel and liver enzyme tests). Other objectives were to assess patient compliance and satisfaction with splitting tablets...

Cite
Gee M, Hasson NK, Hahn T, et al. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm. 2002;8(6):453-8doi: 10.18553/jmcp.2002.8.6.453.
Gee, M., Hasson, N. K., Hahn, T., & Ryono, R. (2002). Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. Journal of managed care pharmacy : JMCP, 8(6), 453-8. https://doi.org/10.18553/jmcp.2002.8.6.453
Gee, Michael, et al. "Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance." Journal of managed care pharmacy : JMCP vol. 8,6 (2002): 453-8. doi: https://doi.org/10.18553/jmcp.2002.8.6.453
Gee M, Hasson NK, Hahn T, Ryono R. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm. 2002 Nov-Dec;8(6):453-8. doi: 10.18553/jmcp.2002.8.6.453. PMID: 14613379.
Copy Download .nbib Format: NLM
JMCP peer review and editorial process.

Journal of managed care pharmacy : JMCP

Curtiss FR.
PMID: 14613392
J Manag Care Pharm. 2002 Nov-Dec;8(6):523-4. doi: 10.18553/jmcp.2002.8.6.523.

No abstract available.

Cite
Curtiss FR. JMCP peer review and editorial process. J Manag Care Pharm. 2002;8(6):523-4doi: 10.18553/jmcp.2002.8.6.523.
Curtiss, F. R. (2002). JMCP peer review and editorial process. Journal of managed care pharmacy : JMCP, 8(6), 523-4. https://doi.org/10.18553/jmcp.2002.8.6.523
Curtiss, Frederic R. "JMCP peer review and editorial process." Journal of managed care pharmacy : JMCP vol. 8,6 (2002): 523-4. doi: https://doi.org/10.18553/jmcp.2002.8.6.523
Curtiss FR. JMCP peer review and editorial process. J Manag Care Pharm. 2002 Nov-Dec;8(6):523-4. doi: 10.18553/jmcp.2002.8.6.523. PMID: 14613392.
Copy Download .nbib Format: NLM
Direct-to-patient advertising (DTPA) and direct-to-consumer advertising (DTCA) of prescription drugs.

Journal of managed care pharmacy : JMCP

Curtiss FR.
PMID: 14613390
J Manag Care Pharm. 2002 Nov-Dec;8(6):521-2. doi: 10.18553/jmcp.2002.8.6.521.

No abstract available.

Cite
Curtiss FR. Direct-to-patient advertising (DTPA) and direct-to-consumer advertising (DTCA) of prescription drugs. J Manag Care Pharm. 2002;8(6):521-2doi: 10.18553/jmcp.2002.8.6.521.
Curtiss, F. R. (2002). Direct-to-patient advertising (DTPA) and direct-to-consumer advertising (DTCA) of prescription drugs. Journal of managed care pharmacy : JMCP, 8(6), 521-2. https://doi.org/10.18553/jmcp.2002.8.6.521
Curtiss, Frederic R. "Direct-to-patient advertising (DTPA) and direct-to-consumer advertising (DTCA) of prescription drugs." Journal of managed care pharmacy : JMCP vol. 8,6 (2002): 521-2. doi: https://doi.org/10.18553/jmcp.2002.8.6.521
Curtiss FR. Direct-to-patient advertising (DTPA) and direct-to-consumer advertising (DTCA) of prescription drugs. J Manag Care Pharm. 2002 Nov-Dec;8(6):521-2. doi: 10.18553/jmcp.2002.8.6.521. PMID: 14613390.
Copy Download .nbib Format: NLM
Current approaches to asthma management: assessing clinical and economic evidence.

Journal of managed care pharmacy : JMCP

O'Connor RD.
PMID: 14613397
J Manag Care Pharm. 2002 Sep-Oct;8(5):8-17. doi: 10.18553/jmcp.2002.8.1.8.

OBJECTIVE: To review the consistency of scientific, clinical, and economic evidence related to dual-controller therapy with inhaled corticosteroids (ICS) and the inhaled long-acting beta2-agonist (LABA) salmeterol in treating patients whose asthma is not controlled with ICS alone.DATA SOURCES: This...

Cite
O'Connor RD. Current approaches to asthma management: assessing clinical and economic evidence. J Manag Care Pharm. 2002;8(5):8-17doi: 10.18553/jmcp.2002.8.1.8.
O'Connor, R. D. (2002). Current approaches to asthma management: assessing clinical and economic evidence. Journal of managed care pharmacy : JMCP, 8(5), 8-17. https://doi.org/10.18553/jmcp.2002.8.1.8
O'Connor, Richard D. "Current approaches to asthma management: assessing clinical and economic evidence." Journal of managed care pharmacy : JMCP vol. 8,5 (2002): 8-17. doi: https://doi.org/10.18553/jmcp.2002.8.1.8
O'Connor RD. Current approaches to asthma management: assessing clinical and economic evidence. J Manag Care Pharm. 2002 Sep-Oct;8(5):8-17. doi: 10.18553/jmcp.2002.8.1.8. PMID: 14613397.
Copy Download .nbib Format: NLM
Prescription use behavior among medicare beneficiaries with capped prescription benefits.

Journal of managed care pharmacy : JMCP

Cox ER, Henderson RR.
PMID: 14613402
J Manag Care Pharm. 2002 Sep-Oct;8(5):360-4. doi: 10.18553/jmcp.2002.8.5.360.

OBJECTIVE: To evaluate the strategies Medicare beneficiaries adopt to manage their out-of-pocket prescription costs in a prescription drug plan with maximum (.capped.) benefits and to evaluate differences in the likelihood of participating in any one strategy before and after...

Cite
Cox ER, Henderson RR. Prescription use behavior among medicare beneficiaries with capped prescription benefits. J Manag Care Pharm. 2002;8(5):360-4doi: 10.18553/jmcp.2002.8.5.360.
Cox, E. R., & Henderson, R. R. (2002). Prescription use behavior among medicare beneficiaries with capped prescription benefits. Journal of managed care pharmacy : JMCP, 8(5), 360-4. https://doi.org/10.18553/jmcp.2002.8.5.360
Cox, Emily R, and Henderson, Rochelle R. "Prescription use behavior among medicare beneficiaries with capped prescription benefits." Journal of managed care pharmacy : JMCP vol. 8,5 (2002): 360-4. doi: https://doi.org/10.18553/jmcp.2002.8.5.360
Cox ER, Henderson RR. Prescription use behavior among medicare beneficiaries with capped prescription benefits. J Manag Care Pharm. 2002 Sep-Oct;8(5):360-4. doi: 10.18553/jmcp.2002.8.5.360. PMID: 14613402.
Copy Download .nbib Format: NLM
Quality improvement opportunities in health care.making it easy to do it right.

Journal of managed care pharmacy : JMCP

James B.
PMID: 14613407
J Manag Care Pharm. 2002 Sep-Oct;8(5):394-9. doi: 10.18553/jmcp.2002.8.5.394.

No abstract available.

Cite
James B. Quality improvement opportunities in health care.making it easy to do it right. J Manag Care Pharm. 2002;8(5):394-9doi: 10.18553/jmcp.2002.8.5.394.
James, B. (2002). Quality improvement opportunities in health care.making it easy to do it right. Journal of managed care pharmacy : JMCP, 8(5), 394-9. https://doi.org/10.18553/jmcp.2002.8.5.394
James, Brent. "Quality improvement opportunities in health care.making it easy to do it right." Journal of managed care pharmacy : JMCP vol. 8,5 (2002): 394-9. doi: https://doi.org/10.18553/jmcp.2002.8.5.394
James B. Quality improvement opportunities in health care.making it easy to do it right. J Manag Care Pharm. 2002 Sep-Oct;8(5):394-9. doi: 10.18553/jmcp.2002.8.5.394. PMID: 14613407.
Copy Download .nbib Format: NLM
Crossing the quality chasm--pharmacist prescribing, nontraditional interventions, and outcomes-based pharmacist reimbursement (OBPR).

Journal of managed care pharmacy : JMCP

Curtiss FR.
PMID: 14613412
J Manag Care Pharm. 2002 Sep-Oct;8(5):403-4. doi: 10.18553/jmcp.2002.8.5.403.

No abstract available.

Cite
Curtiss FR. Crossing the quality chasm--pharmacist prescribing, nontraditional interventions, and outcomes-based pharmacist reimbursement (OBPR). J Manag Care Pharm. 2002;8(5):403-4doi: 10.18553/jmcp.2002.8.5.403.
Curtiss, F. R. (2002). Crossing the quality chasm--pharmacist prescribing, nontraditional interventions, and outcomes-based pharmacist reimbursement (OBPR). Journal of managed care pharmacy : JMCP, 8(5), 403-4. https://doi.org/10.18553/jmcp.2002.8.5.403
Curtiss, Frederic R. "Crossing the quality chasm--pharmacist prescribing, nontraditional interventions, and outcomes-based pharmacist reimbursement (OBPR)." Journal of managed care pharmacy : JMCP vol. 8,5 (2002): 403-4. doi: https://doi.org/10.18553/jmcp.2002.8.5.403
Curtiss FR. Crossing the quality chasm--pharmacist prescribing, nontraditional interventions, and outcomes-based pharmacist reimbursement (OBPR). J Manag Care Pharm. 2002 Sep-Oct;8(5):403-4. doi: 10.18553/jmcp.2002.8.5.403. PMID: 14613412.
Copy Download .nbib Format: NLM
Relationship of clinical factors to the use of Cox-2 selective NSAIDs within an arthritis population in a large HMO.

Journal of managed care pharmacy : JMCP

Bull SA, Conell C, Campen DH.
PMID: 14613417
J Manag Care Pharm. 2002 Jul-Aug;8(4):252-8. doi: 10.18553/jmcp.2002.8.4.252.

OBJECTIVE: To investigate the degree to which physicians use clinical factors to focus use of Cox-2 selective NSAIDs within an arthritis population.METHODS: Diagnostic codes in the medical records of a large group-model HMO in northern California with approximately 3...

Cite
Bull SA, Conell C, Campen DH. Relationship of clinical factors to the use of Cox-2 selective NSAIDs within an arthritis population in a large HMO. J Manag Care Pharm. 2002;8(4):252-8doi: 10.18553/jmcp.2002.8.4.252.
Bull, S. A., Conell, C., & Campen, D. H. (2002). Relationship of clinical factors to the use of Cox-2 selective NSAIDs within an arthritis population in a large HMO. Journal of managed care pharmacy : JMCP, 8(4), 252-8. https://doi.org/10.18553/jmcp.2002.8.4.252
Bull, Scott A, et al. "Relationship of clinical factors to the use of Cox-2 selective NSAIDs within an arthritis population in a large HMO." Journal of managed care pharmacy : JMCP vol. 8,4 (2002): 252-8. doi: https://doi.org/10.18553/jmcp.2002.8.4.252
Bull SA, Conell C, Campen DH. Relationship of clinical factors to the use of Cox-2 selective NSAIDs within an arthritis population in a large HMO. J Manag Care Pharm. 2002 Jul-Aug;8(4):252-8. doi: 10.18553/jmcp.2002.8.4.252. PMID: 14613417.
Copy Download .nbib Format: NLM
Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study.

Journal of managed care pharmacy : JMCP

Marshall DL, Hazlet TK, Gardner JS, Blough DK.
PMID: 14613418
J Manag Care Pharm. 2002 Jul-Aug;8(4):259-65. doi: 10.18553/jmcp.2002.8.4.259.

BACKGROUND: With the introduction of atypical neuroleptic medications into the marketplace, the use of conventional neuroleptics has fallen, attendant with the perception of a more favorable side-effect profile for the atypical neuroleptics.OBJECTIVE: The purpose of this study was to...

Cite
Marshall DL, Hazlet TK, Gardner JS, et al. Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study. J Manag Care Pharm. 2002;8(4):259-65doi: 10.18553/jmcp.2002.8.4.259.
Marshall, D. L., Hazlet, T. K., Gardner, J. S., & Blough, D. K. (2002). Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study. Journal of managed care pharmacy : JMCP, 8(4), 259-65. https://doi.org/10.18553/jmcp.2002.8.4.259
Marshall, Donna L, et al. "Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study." Journal of managed care pharmacy : JMCP vol. 8,4 (2002): 259-65. doi: https://doi.org/10.18553/jmcp.2002.8.4.259
Marshall DL, Hazlet TK, Gardner JS, Blough DK. Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study. J Manag Care Pharm. 2002 Jul-Aug;8(4):259-65. doi: 10.18553/jmcp.2002.8.4.259. PMID: 14613418.
Copy Download .nbib Format: NLM
The search for better antipsychotics continues.

Journal of managed care pharmacy : JMCP

Curtiss FR.
PMID: 14613430
J Manag Care Pharm. 2002 Jul-Aug;8(4):298-9. doi: 10.18553/jmcp.2002.8.4.298a.

No abstract available.

Cite
Curtiss FR. The search for better antipsychotics continues. J Manag Care Pharm. 2002;8(4):298-9doi: 10.18553/jmcp.2002.8.4.298a.
Curtiss, F. R. (2002). The search for better antipsychotics continues. Journal of managed care pharmacy : JMCP, 8(4), 298-9. https://doi.org/10.18553/jmcp.2002.8.4.298a
Curtiss, Frederic R. "The search for better antipsychotics continues." Journal of managed care pharmacy : JMCP vol. 8,4 (2002): 298-9. doi: https://doi.org/10.18553/jmcp.2002.8.4.298a
Curtiss FR. The search for better antipsychotics continues. J Manag Care Pharm. 2002 Jul-Aug;8(4):298-9. doi: 10.18553/jmcp.2002.8.4.298a. PMID: 14613430.
Copy Download .nbib Format: NLM
Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research.

Journal of managed care pharmacy : JMCP

Alemayehu D, Alvir JM, Jones B, Willke RJ.
PMID: 22074671
J Manag Care Pharm. 2011 Nov-Dec;17(9):S22-6. doi: 10.18553/jmcp.2011.17.s9-a.S22.

No abstract available.

Cite
Alemayehu D, Alvir JM, Jones B, et al. Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research. J Manag Care Pharm. 2011;17(9):S22-6doi: 10.18553/jmcp.2011.17.s9-a.S22.
Alemayehu, D., Alvir, J. M., Jones, B., & Willke, R. J. (2011). Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research. Journal of managed care pharmacy : JMCP, 17(9), S22-6. https://doi.org/10.18553/jmcp.2011.17.s9-a.S22
Alemayehu, Demissie, et al. "Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research." Journal of managed care pharmacy : JMCP vol. 17,9 (2011): S22-6. doi: https://doi.org/10.18553/jmcp.2011.17.s9-a.S22
Alemayehu D, Alvir JM, Jones B, Willke RJ. Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research. J Manag Care Pharm. 2011 Nov-Dec;17(9):S22-6. doi: 10.18553/jmcp.2011.17.s9-a.S22. PMID: 22074671.
Copy Download .nbib Format: NLM
"Ten commandments" for conducting comparative effectiveness research using "real-world data".

Journal of managed care pharmacy : JMCP

Willke RJ, Mullins CD.
PMID: 22074669
J Manag Care Pharm. 2011 Nov-Dec;17(9):S10-5. doi: 10.18553/jmcp.2011.17.s9-a.S10.

No abstract available.

Cite
Willke RJ, Mullins CD. "Ten commandments" for conducting comparative effectiveness research using "real-world data". J Manag Care Pharm. 2011;17(9):S10-5doi: 10.18553/jmcp.2011.17.s9-a.S10.
Willke, R. J., & Mullins, C. D. (2011). "Ten commandments" for conducting comparative effectiveness research using "real-world data". Journal of managed care pharmacy : JMCP, 17(9), S10-5. https://doi.org/10.18553/jmcp.2011.17.s9-a.S10
Willke, Richard J, and Mullins, C Daniel. ""Ten commandments" for conducting comparative effectiveness research using "real-world data"." Journal of managed care pharmacy : JMCP vol. 17,9 (2011): S10-5. doi: https://doi.org/10.18553/jmcp.2011.17.s9-a.S10
Willke RJ, Mullins CD. "Ten commandments" for conducting comparative effectiveness research using "real-world data". J Manag Care Pharm. 2011 Nov-Dec;17(9):S10-5. doi: 10.18553/jmcp.2011.17.s9-a.S10. PMID: 22074669.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 65 entries